Product Information
BISMUTH 262 MG TABLET CHEW is a generic product labeled by Major Pharmaceuticals, priced at $0.0817 per EA under NDC 00904720546. Its NADAC has been published 246 times since Jan 19, 2022.
Strength
262 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904720546
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BISMUTH SUBSALICYLATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M008On Market Since
10/11/2021
Price Statistics
The NADAC for BISMUTH 262 MG TABLET CHEW has been published 246 times since Jan 19, 2022, and over the history we have for it it has declined 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0817 per EA |
|---|---|
| All-time high | $0.0890 (Mar 16, 2022) |
| All-time low | $0.0690 (Sep 20, 2023) |
| 52-week high | $0.0854 |
| 52-week low | $0.0809 |
| Median price | $0.0795 |
| Average price | $0.0788 |
| Largest weekly change | +12.5% (Aug 21, 2024) |
| Weeks tracked | 246 |
| Tracking since | Jan 19, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bismuth subsalicylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BISMUTH 262 MG TABLET CHEW?
The current National Average Drug Acquisition Cost (NADAC) for BISMUTH 262 MG TABLET CHEW, manufactured by Major Pharmaceuticals, is $0.0817 per EA (NDC 00904720546), effective Sep 30, 2026.
How has the price of BISMUTH 262 MG TABLET CHEW changed over time?
Over the history we have for it, the NADAC for BISMUTH 262 MG TABLET CHEW has declined 6.1%. It has been tracked across 246 weekly CMS publications since Jan 19, 2022.
What are the highest and lowest recorded NADAC prices for BISMUTH 262 MG TABLET CHEW?
Since Jan 19, 2022, the NADAC for BISMUTH 262 MG TABLET CHEW has ranged from a low of $0.0690 (Sep 20, 2023) to a high of $0.0890 (Mar 16, 2022), with a median of $0.0795 per EA.
Are there cheaper alternatives to BISMUTH 262 MG TABLET CHEW?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BISMUTH 262 MG TABLET CHEW in a comparable dosage form, but none are currently priced below it.
Who manufactures BISMUTH 262 MG TABLET CHEW?
BISMUTH 262 MG TABLET CHEW (NDC 00904720546) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.